Draft report on the development of a harmonised approach to exposure assessment methodologies for residues from veterinary medicinal products, feed additives and pesticides in food of animal origin

July 5, 2022

Tractor spraying a field of crops.

In 2020, the European Commission (EC) requested EMA and European Food Safety Authority (EFSA) for advice for the development of a harmonised approach on exposure assessment methodologies for residues from veterinary medicinal products (EMA), feed additives and pesticides in food of animal origin (EFSA). This work was undertaken under the EC mandate by a working group composed of CVMP experts, EFSA experts, specialists with expertise from the Joint FAO / WHO Expert Committee on Food Additives (JECFA) and the Joint Meeting on Pesticide Residues (JMPR), and an European Chemichal Agency (ECHA) observer. The draft report compares available models of consumer exposure and makes recommendation on a harmonised approach to be used by EMA and EFSA for the assessment of exposure to residues of veterinary medicines, feed additives and pesticides in food of animal origin.

Download the Draft Report

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs

TAGS:

February 24, 2016

FDA Submissions for Interoperable Medical Devices – Comment Period Extended for Draft Guidance

Additional information on FDA’s recommendations for interoperable medical devices is available in our blog post entitled “A Closer Look at FDA’s Draft Guidance Regarding Premarket Submissions for...

August 28, 2015

FDA Extends Comment Period For Its “Request for Quality Metrics” Draft Guidance

Last month, FDA published a draft guidance titled “Request for Quality Metrics,” which outlined the ways in which it intends to collect and use quality metrics. The guidance states that the data will...

December 8, 2015

FDA Will Hold Public Workshop on Medical Device Cybersecurity

In collaboration with the National Health Information Sharing Analysis Center (NH-ISAC) and the Department of Health and Human Services, FDA is planning to hold a public workshop entitled “Moving...